NCT02373397 - Cacicol20® in Corneal Wound Healing and Nerve Regeneration After Phototherapeutic Keratectomy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Corneal Dystrophy, Epithelial Basement MembraneEpithelial Recurrent Erosion DystrophyCorneal Erosions

Interventions

DEVICE

Cacicol20

Investigational device, regenerating agent, single-use doses, topical eye drops. Indicated for corneal wound healing.

DEVICE

Placebo

Vehicle only in identical packaging, with identical dosage and administration route.

Trial Locations (2)

Linköping University Hospital, Linköping

Sahlgrenska University Hospital, Mölndal